Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.

Wegovy will now be the GLP-1 weight loss drug of choice under plans that are managed by CVS Caremark. If they stay on Zepbound for their GLP-1 weight loss treatment, they will have to pay full ...

CVS Caremark said in May that the move will save its employer clients 10 to 15% when compared to the previous year, the newspaper reported. Some employers won’t pay for either treatment because ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

If Caremark does not pay millions it says it’s owed, the plan may need to require every active member to pay an additional $100 in annual premiums starting in 2026.

The Treasurer's Office said in a news release Thursday that 18 months of contract negotiations have resulted in “an untenable impasse" with CVS Caremark, "which potentially endangers the ...

A family-run homecare company which is marking its 10th anniversary in 2025 has further reason to celebrate after once again being named as one of the top 20 recommended providers in the Yorkshire ...

Starting Tuesday, CVS Caremark – a major pharmacy benefit manager that serves as a middleman for health insurers, large employers and other payers to manage their prescription drug plans ...